Clinical Trials List
Protocol Number150-CL-029
Not yet recruiting
2006-12-01 - 2008-03-01
Phase II
Terminated1
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
240 participants
